Rare Enterprises and Quadria Capital-backed Concord Biotech files DRHP for IPO
MUMBAI, 16 AUGUST, 2022 (GPN): Ahmedabad-based Concord Biotech Limited, one of the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on volume in 2021 has filed…